Detection of endometrial intraepithelial neoplasia (EIN) in postmenopausal endometrium

Maturitas

Volumn 46, Issue 2, 2003, Pages 153-161

  Maia Jr , Hugo ^a   Maltez, Amélia ^a   Athayde, Célia E ^a   Coelho, Genevieve ^a   Coutinho, Elsimar ^a  

^a Centro De Pesquisa E Assistencia Em Reproducao Humana   (Brazil)

Author keywords

Endometrial intraepithelial neoplasia; Postmenopausal endometrium; PTEN, bcl 2

Indexed keywords

PHOSPHATASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BCL 2; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER CYTODIAGNOSIS; CARCINOMA IN SITU; CONTROLLED STUDY; ENDOMETRIOID CARCINOMA; ENDOMETRIUM ATROPHY; ENDOMETRIUM HYPERPLASIA; ENDOMETRIUM TUMOR; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ISOLATION AND PURIFICATION; MAJOR CLINICAL STUDY; PATHOLOGY; POLYP; POSTMENOPAUSE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTO ONCOGENE; TUMOR DIAGNOSIS;

EID: 0141922919     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(03)00186-5     Document Type: Article

References (17)

1. Inoue M. Current molecular aspects of the carcinogenesis of the uterine endometrium. Int. J. Gynecol. Cancer. 11:2001;339-348.
2. Mutter G.L. Histopathology of genetically defined endometrial precancers. Int. J. Gynecol. Pathol. 19:2000;301-309.
3. Dietel M. The histological diagnosis of endometrial hyperplasia. Is there a need to simplify. Virchows Arch. 439:2001;604-608.
4. Mutter G.L. Endometrial intraepithelial neoplasia (EIN). Will it bring order to chaos? The Endometrial Collaborative Group. Gynecol. Oncol. 76:2000;287-290.
5. Mutter G.L., Lin M.C., Fitzgerald J.T., Kum J.B., Baak J.P., Lees J.A., Weng L.P., Eng C. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J. Natl. Cancer Inst. 92:2000;924-930.
6. Niemann T.H., Trgovac T.L., McGaughy V.R., Vaccarell L. bcl-2 expression in endometrial hyperplasia and carcinoma. Gynecol. Oncol. 63:1996;318-322.
7. Henderson G.S., Brown K.A., Perkin S.L., Abbot T.M., Clayton F. bcl-2 is down-regulated in atypical endometrial hyperplasia and adenocarcinoma. Mod. Pathol. 9:1996;430-438.
8. Kanamori Y., Kigawa J., Itamochi H., Shimada M., Takahashi M., Kamazawa S., Sato S., Akeshima R., Terakawa N. Correlation between loss of PTEN expression and Akt phosphorylation in endometrial carcinoma. Clin. Cancer Res. 7:2001;892-895.
9. Bussaglia E., del Rio E., Matias-guiu X., Prat J. PTEN mutations in endometrial carcinomas: a molecular and clinicopathological analysis of 38 cases. Hum. Pathol. 31:2000;312-317.
10. Kurman R., Kaminsk P., Norris H. The behavior of endometrial hyperplasia: a long-term study of untreated hyperplasia in 170 patients. Cancer. 56:1985;403-412.
11. Mutter G.L., Baak J.P.A., Crum C.P., Richard R.M., Ferenczy A., Faquin W.C. Endometrial precancer diagnosis by histopathology, clonal analysis and computerized morphometry. J. Pathol. 190:2000;462-469.
12. Jovanovic A.S., Boynton K.A., Mutter G.L. Uteri of women with endometrial carcinoma contain a histopathologic spectrum of monoclonal putative precancers, some with microsatellite instability. Cancer Res. 56:1996;1917-1921.
13. Deligdish L., Holinka C.F. Endometrial carcinoma: two diseases. Cancer Detect. Prev. 10:1987;237-246.
14. Sherman M.E. Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod. Pathol. 13:2000;95-308.
15. Kovalev S., Marchenko N.D., Gugliotta B.G., Chalas E., Chumas J., Moll U.M. Loss of p53 function in uterine papillary serous carcinoma. Hum. Pathol. 29:1998;613-619.
16. Mutter G.L., Lin M.C., Fitzgerald J.T., Kum J.B., Ziebold U., Eng C. Changes in endometrial PTEN expression throughout the human menstrual cycle. J. Clin. Endocrinol. Metabol. 85:2000;2334-2338.
17. Sivridis E., Giatromanolaki A. Prognostic aspects on endometrial hyperplasia and neoplasia. Virchows Arch. 439:2001;118-126.